The following story was reported by The Utah Investigative Journalism Project in partnership with KUER, The Standard-Examiner ...
The use of powerful synthetic opioids, such as sufentanil and remifentanil, during surgery is linked to a subsequent poor ...
The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
The NBA issued a 25-game suspension to Milwaukee Bucks forward Bobby Portis Jr. for a violation of the anti-drug policy, the ...
The following story was reported by The Utah Investigative Journalism Project in partnership with the Standard-Examiner. The ...
One of the scariest moments of my life happened in 2022 when my father, Tom Donvito, then 75 and unaware of any allergies, experienced an anaphylactic reaction to a hornet sting. After he passed ...
The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.
the other introduced in the Senate last year — aim to amend Medicare so older Americans can more easily access and afford a list of certain non-opioid pain medications. Journavx is eligible to ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results